Mumbai: Shares of Manipal Health Enterprises (Manipal Hospitals) listed at a premium of up to an 11% over the initial public offer price of ₹590 on Wednesday.The stock debuted at ₹652 on the NSE and at ₹655 on the BSE. It touched an intraday high of ₹675.80 on the NSE and ₹676.05 on the BSE before closing at ₹663.15 on the NSE and ₹666.70 on the BSE.The company's market capitalisation was at ₹87,229.24 crore at close. The market value of one of the country's largest listed hospital chains was at ₹128,112 crore on Tuesday.The ₹9,275-crore IPO, which was open for subscription from July 29 to July 31, was subscribed 4.92 times. Temasek-backed Manipal Health had fixed the price band at ₹560-590 per equity share.Read Also: NFO Insight: Edelweiss Nifty REITs & Realty Index Fund opens for subscription. Can its 60:40 REIT-realty mix deliver?It was the second-largest IPO this year after SBI Funds Management's ₹9,795-crore issue, which was subscribed 41.73 times. The offering comprised a fresh issue of shares worth ₹8,000 crore and an offer for sale (OFS) of 2.16 crore equity shares, aggregating to ₹1,275.2 crore, by promoters and existing investors.
Manipal Health lists at 11% premium
Manipal Health Enterprises celebrated a successful market entry on Wednesday, with shares launching at ₹652 on the NSE and ₹655 on the BSE, achieving an eleven percent premium. By closing time, the company's market capitalization reached ₹87,229.24 crore. Their impressive initial public offering, valued at ₹9,275 crore, saw nearly five times subscription, making it the year's second-largest IPO, following SBI Funds Management's offering.
Manipal Health listed at ₹652, 11% above IPO price, with ₹9,275-crore subscription 4.92x, India's second-largest public offering this year. The IPO signals digital health as institutional-grade asset in India, validating tele-medicine and health-tech stacks as consolidation targets.








